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NOSOCOMIAL TRANSMISSION OF HEPATITIS C VIRUS
ASSOCIATED WITH THE USE OF MULTIDOSE SALINE
VIALS
Gérard Krause, MD, DrMed; Mary Jo Trepka, MD, MPH; Robert S. Whisenhunt; Dolly Katz, PhD; Omana Nainan, PhD;
Steven T. Wiersma, MD, MPH; Richard S. Hopkins, MD, MSc
Several outbreaks of nosocomial transmission of
hepatitis C virus (HCV) have been linked to breaches in
standard precautions for blood-borne infections during
nursing procedures1 or interventions such as colonoscopy,2
surgery,3 and dialysis.3 In other reports of HCV outbreaks,
although the route of transmission could not be identified,
failure to follow standard procedures was suspected in
most instances.4-11 In reports on other types of outbreaks,
saline flushes of indwelling peripheral intravenous cannu-
las have been linked to nosocomial transmission of
pathogens other than HCV.12-16
In August 1999, three patients diagnosed as having
HCV infection within 8 weeks of being discharged from the
same hospital in southern Florida were reported to the
Florida Department of Health. All three patients had been
hospitalized in the same ward of a 150-bed hospital between
November 11 and 19, 1998. The results of previous tests for
hepatitis A and B were negative. Hospital officials conducted
an internal investigation, including testing of most hospital
staff members for antibody to HCV (anti-HCV), but were
unable to identify the source of the outbreak. All serum sam-
ples from staff members were negative for anti-HCV.
Subsequently, the Florida Department of Health was asked to
investigate the outbreak to identify its source. We conducted
an epidemiologic investigation of patient-to-patient transmis-
sion of HCV that identified exposure to saline flushes as a risk
factor for infection.
METHODS
Case Definitions and Case Ascertainment
An acute case was defined as a patient hospitalized in
the ward between November 11 and 19, 1998, with (1) a
positive antibody test against HCV; (2) onset of jaundice
after November 26, 1998; (3) serum aminotransferase lev-
els greater than 1,000 IU/L; and (4) no evidence of prior
HCV infection. A chronic case was defined as a patient hos-
pitalized in the ward between November 11 and 19, 1998,
with a diagnosis of HCV infection before admission. An
indeterminate case was defined as a patient hospitalized in
the ward between November 11 and 19, 1998, with (1) a
positive antibody test against HCV and (2) no evidence of
jaundice, elevated serum aminotransferase levels, or prior
HCV infection.
Patients hospitalized in the ward between November
11 and 19, 1998, were contacted either directly or through
their primary physicians. Patients were informed of the
possible nosocomial transmission of hepatitis C and were
offered a test for HCV infection. Serum samples of patients
were tested first by enzyme immunoassay (EIA) (HCV-EIA
version 3.0, Ortho-Clinical Diagnostics, Rochester, NY).
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OBJECTIVE: To identify the source of an outbreak of
acute hepatitis C virus (HCV) infection among 3 patients occurring
within 8 weeks of hospitalization in the same ward of a Florida hos-
pital during November 1998.
DESIGN: A retrospective cohort study was conducted
among 41 patients hospitalized between November 11 and 19,
1998. Patients’ blood was tested for antibodies to HCV, and HCV
RNA–positive samples were genotyped and sequenced.
RESULTS: Of the 41 patients, 24 (59%) participated in
the study. HCV genotype 1b infections were found in 5 patients.
Three of 4 patients who received saline flushes from a multidose
saline vial on November 16 had acute HCV infection, whereas
none of the 9 patients who did not receive saline flushes had
HCV infection (P = .01). No other significant exposures were
identified. The HCV sequence was available for 1 case of acute
HCV and differed by a single nucleotide (0.3%) from that of the
indeterminate case.
CONCLUSION: This outbreak of HCV probably occurred
when a multidose saline vial was contaminated with blood from an
HCV-infected patient. Hospitals should emphasize adherence to
standard procedures to prevent blood-borne infections. In addi-
tion, the use of single-dose vials or prefilled saline syringes might
further reduce the risk for nosocomial transmission of blood-
borne pathogens (Infect Control Hosp Epidemiol 2003;24:122-127).
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Samples that were repeatedly reactive by EIA were subse-
quently confirmed by RIBA HCV 3.0 Strip Immunoblot
Assay (Chiron Corp., Emeryville, CA).
Review of Medical Records and Patient
Interviews
The medical records of all patients hospitalized in the
ward between November 11 and 19, 1998, were reviewed.
Data on medical history, diagnosis, diagnostic procedures,
surgical interventions, medications, and other treatments
were collected. Any medication or diagnostic procedure
that involved access to the patient’s vascular system was
recorded with the day and time of exposure. These expo-
sures included intravenous medication, infusions, transfu-
sions, phlebotomy, and capillary blood sugar tests.
Patients who tested positive for anti-HCV were inter-
viewed regarding symptoms, medical history, and risk fac-
tors for hepatitis C. Risk factors were defined as any of the fol-
lowing: injection drug use, history of sexually transmitted
diseases, hemodialysis, blood transfusions or blood compo-
nents before 1992, organ transplants before 1992, or receipt
of clotting factor concentrates produced before 1987.17
Retrospective Cohort Study
A retrospective cohort study was conducted among
patients who were tested for anti-HCV, using the case clas-
sification as the outcome variable. Indeterminate and
chronic cases were excluded from the analysis because
their status as a source or recipient of infection could not be
determined with certainty. Exposures shared by acute case
patients were analyzed by day and time of exposure. Six
time periods per day of 1 to 6 hours each were defined to
compare exposures. Longer time periods were chosen for
hours during which few medical or nursing interventions
occurred, and shorter time periods were chosen for times
of frequent exposures. P values (Fisher’s exact test) were
calculated using Epi-Info software (version 6.0; Centers for
Disease Control and Prevention, Atlanta, GA).
Genotyping and Sequencing of HCV
Anti-HCV–positive specimens were tested for HCV
RNA by nested reverse transcription polymerase chain
reaction (RT PCR) amplification of the 5’ noncoding
region.18,19 PCR products were separated by electrophore-
sis on a 2% agarose (GIBCO-BRL, Carlsbad, CA) and by
positive specimens identified with ethidium bromide stain-
ing.
HCV genotypes were determined for HCV RNA–pos-
itive specimens from the 300-nucleotide–long sequence of
the nonstructural coding region 5b (NS5b).19-21 PCR prod-
ucts were purified and sequenced using an automated DNA
sequencer (ABI 377, Applied Biosystems Inc., Foster City,
CA). Genotypes were defined using a multiple sequence
alignment program (Pileup, Wisconsin Genetic Computer
Group, Madison, WI).22
To determine the relatedness of HCV isolates, quasi-
species of the hypervariable region 1 were determined by
limiting dilution PCR for each HCV RNA–positive specimen
as described below. Nested RT PCR was performed to deter-
mine the endpoint titer, using the following primers: first
round 1350F1 (forward primer 5’-GCTACTCCGGATCCC
ACAAGC-3’) and 1633R (reverse primer 5’-
TCATTGCAGTTCAGGGCCGT-3’), and second round
1426F1 (forward primer 5’-TATTCCATGGTGGGGAACTGG
-3’) and 1619R (reverse primer 5’-GCAGTCCTGTTGATG
TGCCA-3’). Multiple PCR reactions (30 to 40) were then per-
formed at twice the serum dilution of the endpoint PCR titer.
Each PCR amplicon was purified, and the nucleotide
sequence determined as described previously.
Pairwise analysis of nucleotide sequences was per-
formed using multiple sequence alignment programs
(Pileup and Pretty, Wisconsin Genetic Computer Group).
Distribution of nucleotide distances was calculated using
Jukes–Cantor distance correction (Evolutionary Distance,
Wisconsin Genetic Computer Group).
Site Inspection and Review of Procedures
The ward was visited on August 25 and 26, 1999, and
the materials used to administer medications were inspect-
ed. Staff assignment sheets were reviewed to determine
which patients shared the same nurses during each shift.
Staff members were asked to demonstrate procedures that
involved phlebotomy, intravenous medication, or any other




Between November 11 and 19, 1998, a total of 41
patients were hospitalized on the ward. By the time the
investigation was started in August 1999, 15 (37%) of the
patients had died; none of these patients had hepatitis or
liver disease listed as a cause of death on the death certifi-
cate. Two (5%) of the patients could not be located. Thus,
24 (59%) of the patients were available to provide blood
samples for testing. Five (21%) of the 24 samples were pos-
itive for anti-HCV.
Review of Medical Records and Patient
Interviews
Twenty-one women and 20 men comprised the 41
patients hospitalized in the ward between November 11
and 19, 1998. Patients’ ages ranged from 18 to 93 years,
with a median of 77 years. The mean age of the 24 patients
(12 women and 12 men) who were tested for anti-HCV was
72 years versus a mean age of 83 years for the 17 patients
(9 women and 8 men) who were not tested. The mean
length of hospitalization was 10 days. Admission diagnoses
included a variety of cardiac, gastrointestinal, traumatic,
and gynecologic problems. Most admissions resulted from
geriatric health problems. Thirty-nine (95%) of the patients
had an indwelling peripheral intravenous cannula, 10 (24%)
of the patients underwent surgery, 6 (14%) of the patients
underwent gastroenterologic interventions, 5 (12%) of the
patients underwent radiologic imaging with contrast medi-
um, 3 (7%) of the patients had a central venous catheter,
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and 6 (15%) of the patients underwent other invasive inter-
ventions.
According to the medical history and laboratory
results, 3 patients had acute cases (patients A, B, and C), 1
patient had an indeterminate case (patient D), and 1 patient
had a chronic case (patient E) of hepatitis C (Table 1). All
5 case-patients received intravenous medications through
indwelling peripheral intravenous cannulas, but they did
not have the same medications in common. None of the
case-patients underwent surgery, gastroscopy, dialysis, or
a blood transfusion during their hospitalization in the ward.
The exposures shared by all 3 acute case-patients (patients
A, B, and C) were having an indwelling peripheral intra-
venous cannula, receiving any kind of intravenous medica-
tion, receiving saline flushes of the indwelling peripheral
intravenous cannula, and undergoing venous phlebotomy.
Patients A and B had intramuscular medication, and
patients A and C received nebulizer treatments. Patient B
underwent a spinal tap, and patient C underwent subcuta-
neous insulin and capillary blood tests.
The onset of signs and symptoms of acute hepatitis C
occurred in patients A, B, and C during December 1998
and January 1999; none of these patients had identified risk
factors for HCV infection. Patient D died in November 1999
without developing signs or symptoms of hepatitis. This
patient had received multiple blood transfusions from 1997
to 1999 but not during his hospitalization in the ward in
November 1998. Although this patient could not be inter-
viewed, his relatives and primary care physicians reported
no knowledge of any risk factors for HCV infection. Patient
E had been diagnosed as having HCV infection in 1990; she
had received multiple blood transfusions in 1975 in Cuba
and reported no other risk factors for HCV infection.
Retrospective Cohort Study
Twenty-four patients were included in the cohort
study; 3 of these patients had acute hepatitis C (patients A, B,
and C) and were considered acute cases. The remaining 19
patients tested negative for anti-HCV. Patients D and E were
excluded from the analysis. Exposure to indwelling peripher-
al intravenous cannulas was tested for the entire period of
hospitalization because the dates on the installation or
exchange of the cannulas were not available. The only expo-
sure that yielded a trend for an association with acute HCV
infection was saline flush of indwelling peripheral intravenous
cannulas. During six time periods of 1 to 6 hours each, all 3
acute case-patients received a saline flush. During those
times, the only exposure significantly associated with acute
HCV infection was the saline flush on November 16 at 10:00
pm (Table 2). This was one of four times during which patient
D, the indeterminate case-patient, received a saline flush
before the 3 acute case-patients.
Genotyping and Sequencing of HCV
The genotype of all five samples was 1b. Samples
from patients B, D, and E were PCR positive and were
sequenced. Two samples could not be sequenced (patients
A and C) because viral material was no longer available. In
a pairwise analysis, the sequences of the NS5b region of
the HCV from patients B and D differed by a single
nucleotide (0.3%), and the HCV from patient E differed
from the virus from patients B and D by 9 nucleotides (3%).
Relatedness of HCV isolates was evaluated by
hypervariable region 1 quasi-species analysis. A single
hypervariable region 1 quasi-species with identical
sequence was obtained from the HCV from patient B by lim-
iting dilution PCR (n = 20 amplicons). Multiple quasi-species
variants were isolated from patient D (n = 16 amplicons) and
patient E (n = 19 amplicons) with sequence variation between
each other ranging from 0% to 2%. The hypervariable region
1 quasi-species sequences of the HCV from patients B and D
varied by a single nucleotide. The nucleotide identity was 99%
between the sequences of the HCV from patients B and D.
The hypervariable region 1 sequences obtained by limiting
dilution PCR from the HCV from patient E had only 72% iden-
tity with the HCV from patients B and D.
Site Inspection and Review of Procedures
The ward had three rooms with two beds and 12 sin-
gle-bed rooms, and was divided into two sections with nine
TABLE 1
CHARACTERISTICS OF PATIENTS WITH HEPATITIS C VIRUS INFECTION AS OF AUGUST 1999 WHO WERE HOSPITALIZED IN THE SAME WARD
BETWEEN NOVEMBER 11 AND 19, 1998
Age Anti-HCV Test Onset of Admission Dates of Risk Case
Patient (y)     Gender Before Admission Jaundice Diagnosis Stay in Ward Factors? Classification
A 34          M Negative 11/95 1/17/99 Asthma 11/11/98–11/17/98 No Acute
B 18          F Not done 12/5/98 Guillain–Barré 11/12/98–11/19/98 No Acute
syndrome
C 51          F Not done 1/7/99 Asthma 11/12/98–11/19/98 No Acute
D 82          M Not done None Chronic obstructive 11/13/98–11/18/98 Unknown Indeterminate
pulmonary disease
E 66          F Positive 1990 1990 Pancreatitis 11/13/98–12/13/98 Yes Chronic
Anti-HCV = antibody to hepatitis C virus.
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patients in each section. There were two nursing teams;
each team was primarily responsible for one of the two sec-
tions. Patients C and E shared one room, which was locat-
ed across the hall from the room of patient A in the first sec-
tion. Patients B and D stayed in two adjacent single-bed
rooms in the second section.
The hospital used a computerized system for drugs
and nursing supplies that kept individual accounts of all
items used for each patient. This system prevented the
sharing of medications and nursing supplies. The only
medication that was not individually stored and assigned
for patient use was saline solution used to prepare flushes
of indwelling peripheral intravenous cannulas. The saline
solution was in 30-mL multidose vials that were stored on a
medication cart and used by all nurses in both sections of
the ward. Only one vial was opened at a time. Saline flush-
es were performed before and after each intravenous med-
ication or by schedule, usually once per nursing shift.
Nurses were able to explain the standard precautions
for the prevention of blood-borne infections and stated that
they adhered to the precautions. According to interviews
with the nurses, the saline flushes were prepared by insert-
ing a single-use needle into the multidose vial and drawing
approximately 3 mL into a single-use syringe. The needle
was then discarded, and the syringe was connected direct-
ly to the indwelling peripheral intravenous cannulas, inject-
ing the saline solution. On the basis of the nurse assign-
ment sheets, the 3 acute case-patients did not share the
same nurse during any shift.
DISCUSSION
The results of this epidemiologic investigation sug-
gest that three patients were infected with HCV by injection
of saline solution from a multidose vial that might have
been contaminated with the blood of another patient. Five
lines of evidence support this conclusion. First, the HCV
infection of all five case-patients had genotype 1b, which
has an estimated prevalence of 17% among HCV-infected
individuals in the general U.S. population.19 Second, the
sequencing results demonstrate a close genetic resem-
blance between the viruses of one acute case-patient
(patient B) and the indeterminate case-patient (patient D),
suggesting patient-to-patient transmission. Third, saline
solution was the only substance for intravenous use in the
ward that was kept in multidose vials to be used for more
than one patient. Fourth, the epidemiologic analysis identi-
fied exposure to saline flushes as the only significant risk
factor for acute HCV infection. Fifth, the indeterminate
case-patient received a saline flush before the three acute
case-patients on November 16 at 10:00 pm, which is consis-
tent with the possibility of the saline solution being conta-
minated with the blood of the indeterminate case-patient.
Although all five patients with HCV infection had
genotype 1b, the sequencing results indicated that patient
E (the chronic case) was not connected to patients B (an
acute case) and D (the indeterminate case). The larger
variation of quasi-species for the virus from patient D would
be consistent with the hypothesis that his infection was of
longer duration than patient B’s infection.23 If this outbreak
resulted from a single incident, patient D was the most like-
ly source for infection of patients A, B, and C.
We could not determine exactly how the saline solu-
tion was contaminated with HCV, especially because the
nurses said they adhered to the standard precautions
against transmission of blood-borne pathogens and denied
filling the same syringe twice from a multidose vial. The
medication records in the hospital did not always indicate
the order in which patients received saline flushes during a
given time. However, there were four times when the inde-
terminate case-patient received a saline flush before the
TABLE 2
EXPOSURES* AMONG PATIENTS WITH HEPATITIS C VIRUS INFECTION HOSPITALIZED IN THE SAME WARD BETWEEN NOVEMBER 11 AND 19,
1998
Acute HCV Infections Acute HCV Infections
Type and Time of Exposure Among Exposed Among Unexposed P Value
Intravenous injection, Nov. 11–19 3/12 0/10 .14
Indwelling peripheral intravenous cannula, Nov. 11–19† 3/19 0/2 .73
Venous blood test, Nov. 11–19 3/20 0/2 .74
Saline flush, Nov. 11–19 3/14 0/8 .24
Nov. 14: 6:00–10:00 pm‡ 3/7 0/2 .42
Nov. 14–15: 10:00 pm–1:00 am§ 3/7 0/2 .42
Nov. 15: 12:00–6:00 pm‡ 3/6 0/3 .24
Nov. 15: 10:00 pm§ 3/5 0/4 .12
Nov. 16: 9:00 am–3:00 pm‡ 3/7 0/6 .12
Nov. 16: 10:00 pm‡ 3/4 0/9 .01
HCV = hepatitis C virus.
*Exposures shared by at least 2 cases.
†Total is 21 patients instead of 22 patients as for other exposures because information was not available for 1 patient.
‡Time periods  6 hours during which all 3 acute case-patients received a saline flush within 1 hour after the indeterminate case-patient received a saline flush.
§Time periods  6 hours during which all 3 acute case-patients received a saline flush.
Fisher’s exact test.
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three acute case-patients. A possible scenario is that the 3-
mL saline flush in the source patient was not sufficient to
clear the indwelling peripheral intravenous cannula, and
the nurse used the same syringe to draw an additional 3 mL
from the multidose vial for a second flush. When the
syringe was connected to the indwelling peripheral intra-
venous cannula the first time, the syringe might have
become contaminated. Thus, using the same syringe to
draw an additional 3 mL would subsequently contaminate
the contents of the vial. Similar scenarios have been postu-
lated for other nosocomial transmissions of blood-borne
pathogens.6,13,24,25 In some outbreaks, investigators found
that nurses would reuse syringes or cannulas for saline
flushes for the same patient.24,26 This can occur with both
needleless and traditional needle systems.16
This study has several limitations. First, 17 (41%) of the
41 patients could not be tested for anti-HCV because 15 (37%)
of the patients had died before the investigation started.
However, no history of HCV infection was documented in the
medical records of these patients, and the death certificates
did not mention liver disease. Second, we lacked sequencing
data to determine how closely the virus genomes of patients
A and C were related to the other samples. Third, the inves-
tigation started too late after the event for nurses to be able to
remember any breaches in standard procedures. In addition,
nurses might have been hesitant to admit such behaviors
because they were aware that lawsuits were pending against
the hospital. Fourth, we cannot exclude the possibility of
intentional violation of standard procedures, such as
described in a hepatitis C outbreak in Spain that involved
drug addiction.27 However, the only occasion that any of the
five patients with HCV infection received drugs with the
potential for abuse or addiction was on November 14 when
patient A received lorazepam.
Previous reports of nosocomial HCV transmission
have suggested multidose saline solution vials as a source
for transmission, but epidemiologic associations were not
established.4,6,10,11 Saline flushes and other intravenous
multidose medications have also been reported to transmit
blood-borne pathogens such as malaria, human immuno-
deficiency virus, or bacteria.1,13-16,24-26,28-35 For at least four
reports of nosocomial transmission of blood-borne
pathogens, investigators were able to epidemiologically
link the transmission to saline flushes of indwelling periph-
eral intravenous cannulas. However, none of these reports
included HCV.12,13,15,25
According to an Institute of Medicine report, medical
errors occur at a high rate, and systems need to be
designed to make it difficult for staff to make errors.36
Ideally, adherence to standard procedures would prevent
contamination of a multidose vial or its contents. However,
handling errors occur even among trained staff with ade-
quate procedures in place, particularly during busy peri-
ods.3 Two changes could reduce, although not completely
eliminate, the probability of contaminated saline flush-
es24,37,38: (1) multidose vials could be replaced by single-
dose vials or (2) single-use syringes prefilled with saline
solution would reduce the need for vials entirely. Such
products are available, and some hospitals have their phar-
macy departments fill the syringes and deliver them in ster-
ile packages to the units.37 As a result of this investigation,
the affected hospital has replaced multidose saline vials
with single-dose vials. A cost–benefit analysis for such
interventions is needed, but the additional cost of single-
use saline vials or prefilled syringes is likely to be small.
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